111 Price to Sales Ratio 2018-2026 | YI
Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of September 15, 2026 is .
| 111 P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-09-15 | 3.49 | 0.02 | |
| 2026-03-31 | 6.52 | $189.46 | 0.03 |
| 2025-12-31 | 2.56 | $206.72 | 0.01 |
| 2025-09-30 | 4.55 | $214.33 | 0.02 |
| 2025-06-30 | 7.14 | $225.62 | 0.03 |
| 2025-03-31 | 8.11 | $229.04 | 0.04 |
| 2024-12-31 | 6.23 | $229.93 | 0.03 |
| 2024-09-30 | 7.56 | $241.16 | 0.03 |
| 2024-06-30 | 10.65 | $240.89 | 0.04 |
| 2024-03-31 | 11.60 | $242.97 | 0.05 |
| 2023-12-31 | 15.50 | $250.23 | 0.06 |
| 2023-09-30 | 26.00 | $248.64 | 0.10 |
| 2023-06-30 | 24.60 | $245.69 | 0.10 |
| 2023-03-31 | 26.50 | $243.07 | 0.11 |
| 2022-12-31 | 30.20 | $235.30 | 0.13 |
| 2022-09-30 | 26.80 | $235.75 | 0.11 |
| 2022-06-30 | 20.60 | $241.86 | 0.09 |
| 2022-03-31 | 26.60 | $243.92 | 0.11 |
| 2021-12-31 | 35.00 | $235.18 | 0.15 |
| 2021-09-30 | 61.70 | $222.39 | 0.28 |
| 2021-06-30 | 90.85 | $202.02 | 0.45 |
| 2021-03-31 | 138.00 | $173.39 | 0.80 |
| 2020-12-31 | 69.50 | $152.64 | 0.46 |
| 2020-09-30 | 62.00 | $120.68 | 0.51 |
| 2020-06-30 | 63.50 | $97.40 | 0.65 |
| 2020-03-31 | 66.10 | $84.45 | 0.78 |
| 2019-12-31 | 67.30 | $69.33 | 0.97 |
| 2019-09-30 | 48.70 | $61.90 | 0.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.031B | $1.795B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |